Nifedipina retard vs. alfa-metil-dopa en la hipertension arterial cronica mas toxemia agregada

Cid Troncoso, Juan; Pérez Pérez, Miguelina; Jimenez, Jorge A; Nuñez Diplan, Angel M; Balbi, Martin; Santana, Elvis.
Rev. méd. domin ; 53(2/3): 76-8, abr.-sept. 1992. ilus
Artículo en Español, Inglés | LILACS | ID: lil-132039

Documentos relacionados

  1. Cerebral perfusion pressure in women with preeclampsia is elevated even after treatment of elevated blood pressure.
  2. Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
  3. Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration.
  4. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
  5. Oral regimen management of acute hypertension in pregnancy.
  6. Severe, early-onset hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome episode with spontaneous remission during pregnancy.
  7. Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial.
  8. Antihypertensive drug prescription trends for pregnant women with hypertension in acute hospitals in Japan.
  9. The "Preeclampsia and Hypertension Target Treatment" study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings.
  10. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.